- Suofu, Yalikun;
- Li, Wei;
- Jean-Alphonse, Frédéric G;
- Jia, Jiaoying;
- Khattar, Nicolas K;
- Li, Jiatong;
- Baranov, Sergei V;
- Leronni, Daniela;
- Mihalik, Amanda C;
- He, Yanqing;
- Cecon, Erika;
- Wehbi, Vanessa L;
- Kim, JinHo;
- Heath, Brianna E;
- Baranova, Oxana V;
- Wang, Xiaomin;
- Gable, Matthew J;
- Kretz, Eric S;
- Di Benedetto, Giulietta;
- Lezon, Timothy R;
- Ferrando, Lisa M;
- Larkin, Timothy M;
- Sullivan, Mara;
- Yablonska, Svitlana;
- Wang, Jingjing;
- Minnigh, M Beth;
- Guillaumet, Gérald;
- Suzenet, Franck;
- Richardson, R Mark;
- Poloyac, Samuel M;
- Stolz, Donna B;
- Jockers, Ralf;
- Witt-Enderby, Paula A;
- Carlisle, Diane L;
- Vilardaga, Jean-Pierre;
- Friedlander, Robert M
G protein-coupled receptors (GPCRs) are classically characterized as cell-surface receptors transmitting extracellular signals into cells. Here we show that central components of a GPCR signaling system comprised of the melatonin type 1 receptor (MT1), its associated G protein, and β-arrestins are on and within neuronal mitochondria. We discovered that the ligand melatonin is exclusively synthesized in the mitochondrial matrix and released by the organelle activating the mitochondrial MT1 signal-transduction pathway inhibiting stress-mediated cytochrome c release and caspase activation. These findings coupled with our observation that mitochondrial MT1 overexpression reduces ischemic brain injury in mice delineate a mitochondrial GPCR mechanism contributing to the neuroprotective action of melatonin. We propose a new term, "automitocrine," analogous to "autocrine" when a similar phenomenon occurs at the cellular level, to describe this unexpected intracellular organelle ligand-receptor pathway that opens a new research avenue investigating mitochondrial GPCR biology.